Company / SG&A Expense
Sanara MedTech Inc. SG&A Expense History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$71.7M
FY2025
5-year range
$18.7M / $71.7M
FY2021-FY2025
Trend
+25.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has increased for 8 consecutive years, from $3M in FY2016 to $72M in FY2025.
Based on SEC 10-K filings.
$72M in FY2025 with a 10-year CAGR of +34.0%.
Increased from $46M to $72M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +36.7%
- 5-Year CAGR
- +40.6%
- 10-Year CAGR
- +34.0%
Key checks
Key Insights
- Sanara MedTech Inc.'s sg&a expense has grown for 8 consecutive years.
- 5-year CAGR of +40.6%, indicating consistent growth.
- In FY2025, sg&a expense increased 25.8% year-over-year.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $71.7M | +25.8% |
| FY2024 | $57.0M | +24.0% |
| FY2023 | $46.0M | +63.9% |
| FY2022 | $28.1M | +50.2% |
| FY2021 | $18.7M | +42.9% |
| FY2020 | $13.1M | +147.7% |
| FY2018 | $5.3M | +33.7% |
| FY2017 | $3.9M | +16.8% |
| FY2016 | $3.4M | -11.9% |
| FY2015 | $3.8M | +0.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026